NCT03269591

Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea

Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea: Arandomized Controlled Trial in the Egyptian Women

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Cairo University · Academic / Other
• Sex: Female
• Age: 17 Years – 24 Years
• Healthy volunteers: Not accepted

Summary

Electromagnetic field versus diclofenac drugs on primary dysmenorrhea: Arandomized controlled trial in the Egyptian women

Detailed description

Background: Primary dysmenorrhea is one of the most common complaints of women and is also the most common gynecological problem worldwide. These cramps are recurrent and 90% adolescent girls and about 50% women suffer from it. Purpose of the study: to determine which is more effective in alleviating primary dysmenorrhea; pulsed electromagnetic field or diclofenac drugs. Methodology: The study was a randomized, double-blinded trial, fifty adult females participated in this study, were divided randomly into two groups equal in numbers: group (A) received pulsed electromagnetic field applied on pelvic region, 3 times per week for 3 months, 20 minutes per day and group (B) received diclofenac tablets, 50 mg only with onset of menstrual pain. All participants in both groups (A and B) were assessed pre- and post-treatment through measuring progesterone level in the blood, assessment of pain using visual analogue scale and physical as well as psychological symptoms by using menstrual symptom questionnaire.

Conditions

• Electromagnetic Field
• Dysmenorrhea

Interventions

Type	Name	Description
DEVICE	Pulsed electromagnetic field	EASY Qs portable (by ASA, Italy)
DRUG	diclofenac tablets	drugs
DIAGNOSTIC_TEST	Visual analogue scale	a graphic rating scale
DIAGNOSTIC_TEST	Progesterone blood level	blood test
DIAGNOSTIC_TEST	Menstrual symptom questionnaire	questionnaire

Timeline

• Start date: 2016-02-01
• Primary completion: 2016-09-30
• Completion: 2016-10-29
• First posted: 2017-09-01
• Last updated: 2017-09-01